Wearable Biosensor to Track and Quantify Limb Dysfunction in Multiple Sclerosis Patients

Launched by NANTES UNIVERSITY HOSPITAL · Dec 8, 2017

Keywords

ClinConnect Summary

Multiple sclerosis (MS) is a leading cause of neurological injury in young adults. Capturing the extent of multiple domains of MS-related disability is critical for effective clinical care and the development of new paradigms for patient-focused therapeutic approaches. To date outcomes research in MS has centered on clinical exams, which may be insensitive over the short term (the 1-2 years of early stage clinical trials) and only capture a single snapshot of the patient's performance.

With the mass production of sensors in the gaming and computer control industry, there is an opportunity ...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Aged between 18 to 64 years inclusive (Patients over 64 years will not be enrolled to avoid possible effect of aging on the voluntary movement assessed);
• • Confirmed diagnosis of MS according to the revised McDonald criteria (including primary progressive, secondary progressive and relapsing-remitting MS) with brain lesions consistent with MS if data available;
• • No history of relapse in the previous 5 weeks.
• • Must be able or think they are able to attempt both finger and foot tapping tests, F2NT, 9HPT and be ambulatory with or without assistance.
• Exclusion Criteria:
• • Pregnant women
• • Minors
• • Adults under guardianship
• • Adults over 64 years